Jan;57(1):1-21. \[[PubMed: 31603708](https://pubmed.ncbi.nlm.nih.gov/31603708)\] 23. Vivekanandan S, Swaminathan R. Clinically effective CK-MB reporting: how to do it? J Postgrad Med. 2010 Jul-Sep;56(3):226-8. \[[PubMed: 20739777](https://pubmed.ncbi.nlm.nih.gov/20739777)\] 24. Recommended method for the determination of creatine kinase in blood. Scand J Clin Lab Invest. 1976 Dec;36(8):711-23. \[[PubMed: 1031483](https://pubmed.ncbi.nlm.nih.gov/1031483)\] 25. Kanemitsu F, Okigaki T. Creatine kinase isoenzymes. J Chromatogr. 1988 Jul 29;429:399-417. \[[PubMed: 3062028](https://pubmed.ncbi.nlm.nih.gov/3062028)\] 26. Chen A, Wong SS. Differentiation of creatine kinase MB and IgA-linked BB isoenzymes on electrophoresis. FEBS Lett. 1987 Apr 06;214(1):192-4. \[[PubMed: 3494633](https://pubmed.ncbi.nlm.nih.gov/3494633)\] 27. Ogunro EA, Hearse DJ, Shillingford JP. Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res. 1977 Mar;11(2):94-102. \[[PubMed: 870200](https://pubmed.ncbi.nlm.nih.gov/870200)\] 28. Laurino JP, Fischberg-Bender E, Galligan S, Chang J. An immunochemical mass assay for the direct measurement of creatine kinase MB2. Ann Clin Lab Sci. 1995 May-Jun;25(3):252-63. \[[PubMed: 7605108](https://pubmed.ncbi.nlm.nih.gov/7605108)\] 29. Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta. 2004 Aug 16;346(2):211-9. \[[PubMed: 15256323](https://pubmed.ncbi.nlm.nih.gov/15256323)\] 30. Marwah SA, Shah H, Chauhan K, Trivedi A, Haridas N. Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction. Indian J Clin Biochem. 2014 Apr;29(2):161-6. \[[PMC free article: PMC3990811](/pmc/articles/PMC3990811/)\] \[[PubMed: 24757297](https://pubmed.ncbi.nlm.nih.gov/24757297)\] 31. Seo H, Miyazaki S, Furuno T, Nonogi H, Haze K, Hiramori K. Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level. Jpn Heart J. 1993 Nov;34(6):717-27. \[[PubMed: 8164339](https://pubmed.ncbi.nlm.nih.gov/8164339)\] 32. Obzansky D, Lott JA. Clinical evaluation of an immunoinhibition procedure for creatine kinase-MB. Clin Chem. 1980 Jan;26(1):150-2. \[[PubMed: 7356551](https://pubmed.ncbi.nlm.nih.gov/7356551)\] 33. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44(3):311-6. \[[PubMed: 16519604](https://pubmed.ncbi.nlm.nih.gov/16519604)\] 34. Hedayati M, Razavi SA, Boroomand S, Kheradmand Kia S. The impact of pre-analytical variations on biochemical analytes stability: A systematic review. J Clin Lab Anal. 2020 Dec;34(12):e23551. \[[PMC free article: PMC7755813](/pmc/articles/PMC7755813/)\] \[[PubMed: 32869910](https://pubmed.ncbi.nlm.nih.gov/32869910)\] 35. Timonen A, Lloyd-Puryear M, Hougaard DM, Meriö L, Mäkinen P, Laitala V, Pölönen T, Skogstrand K, Kennedy A, Airenne S, Polari H, Korpimäki T. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP® Neonatal Creatine Kinase-MM Kit in a US and Danish Population. Int J Neonatal Screen. 2019 Sep;5(3):27. \[[PMC free article: PMC7510235](/pmc/articles/PMC7510235/)\] \[[PubMed: 33072986](https://pubmed.ncbi.nlm.nih.gov/33072986)\] 36. Zaninotto M, Mion MM, Novello E, Delprete E, Moretti M, Plebani M. Creatine-kinase MB